等待開盤 06-25 09:30:00 美东时间
-0.095
-7.57%
Tempest Therapeutics shares are trading lower after the company announced the e...
05-30 01:09
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.28) by 78.57 percent. This is a 84.18 percent increase over losses of $(3.16) per share
05-15 05:23
TPST-2003 is an autologous CD19/BCMA dual-targeting CAR-T therapy designed to improve response depth and durability in patients with relapsed/refractory multiple myeloma ("rrMM") through a parallel dual-targeting CAR
04-22 20:10
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(3.52) by 82.39 percent. This is a 87.77 percent increase over losses of $(5.07) per share
03-30 21:06
Tempest Therapeutics, Inc.涨36.78%,报2.38美元
03-26 15:06
Southland Holdings, Inc.涨49.24%;Tempest Therapeutics, Inc.涨36.21%;Rani Therapeutics涨22.81%
03-26 15:01
Southland Holdings, Inc.涨53.03%;Navan, Inc. Class A涨26.45%;Rani Therapeutics涨22.81%
03-26 13:03
Southland Holdings, Inc.涨50.76%;Navan, Inc. Class A涨27.32%;Epsium Enterprise涨22.14%
03-26 09:04
Megan Holdings Limited Class A涨-86.88%;Cibus, Inc. Class A涨-18.82%;Next Technology涨-16.95%
03-26 08:12
Tempest Therapeutics has entered into definitive agreements for the purchase and sale of an aggregate of 925,927 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 925,927
03-23 20:03